Camurus hits bottom of STOXX on 'big' Q4 miss

Camurus AB

12/02/2026 08:52

** Shares in Swedish biotech company Camurus CAMX.ST drop close to 20% after it posted a weaker-than-expected Q4 print

** "Big misses" on revenue and profit lines, Jefferies says, adding that revenue of SEK 464 million was 25% behind consensus and its own estimate

** The revenue miss was partly driven by SEK 93 million one-time inventory repurchase and FX headwinds, the brokerage notes

** Camurus said it expects its full-year revenue to be between SEK 2.6 to 2.9 billion, and operating results to be between SEK 0.9 to 1.2 billion in 2026

** Consensus and Jefferies' estimates are notably above the top-end of the 2026 revenue and operating result range, the broker notes, and adds that the outlook suggests significant  consensus downgrades

**If losses hold, Camurus shares are on track for their worst day in eight years

** Camurus is the weakest performer on the pan-European STOXX 600 .STOXX index

 (Reporting by Elviira Luoma)

 ((Elviira.luoma@thomosnreuters.com))